| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/02/2009 | EP1276483B1 Compositions and methods for treating amyloidosis using sulphonate derivatives |
| 09/02/2009 | EP1262546B1 Novel scavenger receptors |
| 09/02/2009 | EP1087991B1 Prodrugs of dipeptidyl peptidase iv inhibitors |
| 09/02/2009 | CN101519458A Method for extracting tea polysaccharides and tea polyphenol from coarse old green tea |
| 09/02/2009 | CN101519457A Method for preparing beta-ethoxy rutinose and application thereof for reducing blood glucose |
| 09/02/2009 | CN101519394A 3-aryl-coumarin derivatives and preparation method and application thereof |
| 09/02/2009 | CN101519392A Compound treating diabetes and relevant complicating diseases and preparation method and application thereof |
| 09/02/2009 | CN101519363A Substituted naphthylalanine derivative used as protein tyrosine phosphatase 1B (PTP1B) inhibitor |
| 09/02/2009 | CN101518650A Combination of a DPP IV inhibitor and a cardiovascular compound |
| 09/02/2009 | CN101518648A Soluble receptor BR43x2 and methods of using |
| 09/02/2009 | CN101518646A Lipase-containing composition |
| 09/02/2009 | CN101518622A Traditional Chinese medicine for treating diabetes complicated with urinary infection |
| 09/02/2009 | CN101518598A Tea oral tablet and preparation method thereof |
| 09/02/2009 | CN101518597A Application of thearubigins to pharmacy |
| 09/02/2009 | CN101518595A Medical composition with functions of lowering lipid, reducing fat and oxidation resistance and preparation method thereof |
| 09/02/2009 | CN101518591A Traditional Chinese medicine for treating diabetic constipation |
| 09/02/2009 | CN101518588A Traditional Chinese medicine for treating diabetic arthrodynia |
| 09/02/2009 | CN101518575A Traditional Chinese medicine for treating diabetic insomnia |
| 09/02/2009 | CN101518572A Giant knotweed active substance composition with hypoglycemic drug effect |
| 09/02/2009 | CN101518566A Non-oral preparation of guava leaf total flavonoid aglycone, preparation method and application thereof |
| 09/02/2009 | CN101518563A Non-oral preparation of pachyrhizua angulatus total aglycon, preparation method and application thereof |
| 09/02/2009 | CN101518562A Non-oral preparation of kudzuvine root total aglycon, preparation method and application thereof |
| 09/02/2009 | CN101518561A Oral medicinal preparation of kudzuvine root total aglycon, preparation method and application thereof |
| 09/02/2009 | CN101518554A Oral medicinal preparation of hairy holly root total aglycon, preparation method and application thereof |
| 09/02/2009 | CN101518553A Oral medicinal preparation of ginkgo leaf total flavonoid aglycone, preparation method and an application thereof |
| 09/02/2009 | CN101518518A Niacin simvastatin sustained-release preparation and preparation method thereof |
| 09/02/2009 | CN101518516A Sodium riboflavin phosphate lyophilized powder for injection and preparation method thereof |
| 09/02/2009 | CN101518512A Calcium gluconate injection and preparation method thereof |
| 09/02/2009 | CN101518327A Maitake proteoglycan sugar-reducing compound food |
| 09/02/2009 | CN101518325A Edible health-care salt and method for preparing same |
| 09/02/2009 | CN100534997C C-aryl glucoside SGLT2 inhibitors and method |
| 09/02/2009 | CN100534991C Heterocyclic inhibitors of ERK 2 and uses thereof |
| 09/02/2009 | CN100534988C 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
| 09/02/2009 | CN100534438C Difructose anhydride-containing composition and use thereof |
| 09/02/2009 | CN100534436C Polynucleotide therapy |
| 09/02/2009 | CN100534419C Colloidal suspension of nanoparticles based on am amphiphilic copolymer |
| 09/01/2009 | US7582756 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors |
| 09/01/2009 | US7582734 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling |
| 09/01/2009 | US7582669 Aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 09/01/2009 | US7582662 Body weight gain inhibitor |
| 09/01/2009 | US7582660 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 09/01/2009 | US7582657 Vanilloid receptor ligands and their use in treatments |
| 09/01/2009 | US7582654 Antiarrhythmia agents, treating gastrointensinal disorder, gastroesophageal reflux, chronic obstructive pulmonary disease, diabetes;N-cotnaining heterocyclic compound with carbamate or amide groups and indazole ring |
| 09/01/2009 | US7582644 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/01/2009 | US7582642 4-{9-Isopropyl-6-[(pyridin-3-ylmethyl)-amino]-9H-purin-2-ylamino}-2-methyl-hexan-3-ol;antiproliferative agents; viricides; alopecia; strokes; central nervous system diorders; neurodegenerative diseases; antidiabetic agents; mitosis; cyclin dependent kinase inhibitors; protein kinase inhibitors |
| 09/01/2009 | US7582633 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 09/01/2009 | US7582632 Tri(cyclo) substituted amide compounds |
| 09/01/2009 | US7582619 Administering pyrimidine nucleotide precursor where respiratory chain dysfunction is caused by mutation, deletion, or rearrangement of mitochondrial DNA, cytotoxic cancer chemotherapy agents, aging |
| 09/01/2009 | US7582601 Use of peptides derived from whey protein hydrolysate as active ingredients in a medicament or as food ingredient for elevating the cholescystokinin level in the blood, and for preventing or treatment of overweight and/or obesity, in an animal, including humans |
| 09/01/2009 | US7582466 Bacillus subtilis var. chungkookjang producing high molecular weight poly-gamma-glutamic acid |
| 09/01/2009 | US7582445 Anti-interferon-α antibodies |
| 09/01/2009 | US7582440 Imaging, diagnosis and treatment of disease |
| 09/01/2009 | US7582317 Food supplements comprising, as a health component, sargahydroquinoic acid or derivative thereof |
| 09/01/2009 | US7582313 Methods of organ regeneration using Hox 11-expressing pluripotent cells |
| 09/01/2009 | CA2506491C Novel derivatives of pyrrolidines and thiazolidines, process for preparing them and pharmaceutical compositions containing them |
| 09/01/2009 | CA2403977C .gamma.-tocotrienol-containing diuretics |
| 09/01/2009 | CA2210812C T-cell affecting peptides |
| 08/27/2009 | WO2009105722A1 Compounds and compositions as modulators of gpr119 activity |
| 08/27/2009 | WO2009105717A1 Compounds and compositions as modulators of gpr119 activity |
| 08/27/2009 | WO2009105715A1 Compounds and compositions as modulators of gpr119 activity |
| 08/27/2009 | WO2009105548A2 Methods for treating diabetes |
| 08/27/2009 | WO2009104944A1 Adjuvant extract for use against diabetes and related diseases |
| 08/27/2009 | WO2009104706A1 Microparticles and pharmaceutical compositions thereof |
| 08/27/2009 | WO2009104696A1 Oral or enteral composition useful for recovery of physical functions |
| 08/27/2009 | WO2009103953A1 Treatment of energy utilization disease |
| 08/27/2009 | WO2009103739A1 Heterocyclic inhibitors of stearoyl-coa desaturase |
| 08/27/2009 | WO2009103164A1 Anti-obesity compositions comprising orlistat and various natural products |
| 08/27/2009 | WO2009086439A3 2-methylene-(20s,25s)-19,26-dinor-vitamin d analogs |
| 08/27/2009 | WO2009086438A3 2-methylene-(20s,25r)-19,26-dinor-vitamin d analogs |
| 08/27/2009 | WO2009084827A3 Synthetic intermediates, process for preparing pyrrolylheptanoic acid derivatives therefrom |
| 08/27/2009 | WO2009080693A3 Pharmaceutical composition comprising tesofensine or its analogue and a beta blocker |
| 08/27/2009 | WO2009080691A3 Pharmaceutical composition comprising tesofensine or its analogue and an anti-obesity compound |
| 08/27/2009 | WO2009075835A8 CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1 |
| 08/27/2009 | WO2009033811A3 Therapeutic uses of muroctasin and kisspeptin13 and compositions thereof |
| 08/27/2009 | WO2009033760A3 Use of fibronectin fragment (196-203 ) as a therapeutic agent |
| 08/27/2009 | WO2009033667A3 Use of a peptide as a therapeutic agent |
| 08/27/2009 | WO2008116145A3 Soluble epoxide hydrolase inhibitors |
| 08/27/2009 | US20090215995 isolated nucleic acids encoding B7-related polypeptides, including BSL3, which modulate cells that are important for immune and inflammatory responses, such as T-cells |
| 08/27/2009 | US20090215981 Glp-1 Pegylated Compounds |
| 08/27/2009 | US20090215895 Therapeutic and carrier molecules |
| 08/27/2009 | US20090215890 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 08/27/2009 | US20090215852 Compositions and methods for ameliorating cachexia |
| 08/27/2009 | US20090215825 Substituted pyrazoles, compositions containing such compounds and methods of use |
| 08/27/2009 | US20090215805 4-Heteroaryl Pyrimidine Derivatives and use thereof as Protein Kinase Inhibitors |
| 08/27/2009 | US20090215780 Preparation and Use of Aryl Alkyl Acid Derivatives for the Treatment of Obesity |
| 08/27/2009 | US20090215774 Uses of indane compounds |
| 08/27/2009 | US20090215766 Tetracyclic inhibitors of janus kinases |
| 08/27/2009 | US20090215755 Use of a pyrazole derivative for preparing medicinal products that are useful in the prevention and treatment of dyslipidaemias and of diseases related to dyslipidaemias and/or to obesity |
| 08/27/2009 | US20090215748 FXR agonists for treating vitamin D associated diseases |
| 08/27/2009 | US20090215736 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |
| 08/27/2009 | US20090215728 Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, process for preparing them, medicaments comprising these compounds, and their use |
| 08/27/2009 | US20090215718 Carbohydrate composition for flat glucose response |
| 08/27/2009 | US20090215707 Compound having cyclic structure and use thereof |
| 08/27/2009 | US20090215704 Health-related liquid compositions |
| 08/27/2009 | US20090215694 Lyophilized Formulations of Exendins and Exendin Agonist Analogs |
| 08/27/2009 | US20090215681 Methods of Diagnosis and Treatment of Metabolic Disorders |
| 08/27/2009 | US20090215672 Cys-Rich, Cell Surface Glycoproteins |
| 08/27/2009 | US20090215627 Crystal Structure of Biotin Carboxylase (Bc) Domain of Acetyl-Coenzyme a Carboxylase and Methods of Use Thereof |
| 08/27/2009 | US20090214684 Method for reducing body weight and improving control of body lipids |
| 08/27/2009 | US20090214682 Composition and methods for weight loss in a subject |